The Streptomyces subtilisin inhibitor (SSI) is a well-characterized proteinaceous inhibitor of proteases.
6) The structure-function relationships of SSI and SSI-like proteins have been extensively studied in combination with a variety of physicochemical methods and the generation of site-specific mutants. [7] [8] [9] [10] Almost all of these inhibitors exist as dimeric proteins consisting of two identical subunits. 8, 10) A novel monomeric subtilisin inhibitor has been isolated from the culture medium of a Streptomyces species 1-72.
11)
Streptomyces hiroshimensis is known to produce phospholipase and hemolysin. 12, 13) We have recently found that this strain produces a novel ALP with protease inhibitor activity in culture broth. This paper describes the purification and some properties of the enzyme.
MATERIALS AND METHODS

Organism and Growth Conditions S. hiroshimensis
IFO 12785 was obtained from the Institute for Fermentation, Osaka (Juso Nishinocho, Osaka, Japan). The strain was precultured as described in a previous paper, 14) in medium A (200 ml) composed of 1.0% soluble starch, 1.0% glucose, 0.75% meat extract, 0.5% peptone, 0.3% NaCl, and 0.1% MgSO 4 , and stored at 30°C in an orbital shaker at 150 rev/min for 3 d. The culture (10 ml) was transferred and recultured in the new medium A. After further cultivation for 5 d, the mycelium was removed by centrifugation at 4°C, and the supernatant was freeze-dried. The freeze-dried materials were used for the purification of the enzyme.
Enzyme Assay ALP activity was colorimetrically assayed using p-nitrophenyl phosphate (pNPP, Nacalai Tesque) and p-nitrophenylphosphoryl choline (NPPC, Sigma) as substrates. 15) Fifty microliters of enzyme solution was added to 20 mM Tris-HCl buffer 50 ml (pH 8.0) containing 10 mM substrate, and incubated at 37°C for specified times. The reaction was stopped by adding 0.1 M NaOH 100 ml, and the absorbance of the p-nitrophenol formed was measured at 405 nm. The units of activity were calculated as micromoles of p-nitrophenol released per minute. To determine the K m and V max constants, the enzyme was incubated with increasing amounts of substrate and the measured activities from duplicate experiments were plotted in a Hanes-Woolf diagram.
Purification of S-ALP The freeze-dried culture supernatants (8 g) were dissolved in 1 mM Tris-HCl buffer 40 ml (pH 8.0) and applied to a Sephadex G-75 Superfine (Amersham Pharmacia Biotech) column (97ϫ215 mm) equilibrated with the same buffer and then eluted with the buffer. The pieces of prepared palmitoylated gauze (Pal-G) were washed and packed onto the column with 50% ethanol. 16) After washing with water, the column was equilibrated with 1 mM Tris-HCl buffer (pH 8.0). The active fractions from the Sephadex column were applied to the Pal-G column (15ϫ 340 mm). The enzyme adsorbed on the column was eluted with the buffer containing 0.5% (w/v) Triton X-100. The active fractions were further applied to a fast protein liquid chromatography (FPLC) system (Amersham Pharmacia Biotech) using a Superdex 75 HR (Amersham Pharmacia Biotech) gel filtration column (10ϫ300 mm) equilibrated with 1 mM Tris-HCl buffer (pH 8.0) and then eluted with the same buffer.
Protein Quantification The amount of protein was spectrophotometrically determined using a protein assay (BCA Protein Assay, Pierce) with bovine serum albumin as the standard.
17)
Electrophoresis Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed using an 8-25% gradient gel in the PhastSystem under reducing conditions. An appropriate amount of protein was incubated at 90°C for 5 min with 2% (w/v) glycerol and 50 mM dithiothreitol in 58 mM Tris-HCl buffer, pH 6.8, and then subjected to electrophoresis. The gel was stained using a Silver Staining Kit (Amersham Pharmacia Biotech). Nondenaturing SDS-PAGE was carried out in the same system but without dithiothreitol. An LMW Electrophoresis Calibration Kit (Amersham Pharmacia Biotech) was used as the molecular calibration proteins.
Phast Gel IEF 3-9 (Amesham Pharmacia Biotech) on the PhastSystem was used for isoelectric focusing. The gel was stained with Coomassie brilliant blue (Amersham Pharmacia Biotech). A pI Calibration Kit 3-10 (Amersham Pharmacia Biotech) was used as the pI marker.
Molecular Mass Estimation
The relative molecular mass of the purified enzyme was estimated both by FPLC gel filtration on a Superdex 75 HR column and by SDS-PAGE as described above. For the gel filtration method, dextran blue and protein molecular mass standards (Sigma) were applied to the column to obtain a calibration curve.
Determination of N-Terminal Amino Acid Sequence The phosphatase protein (S-ALP) obtained by Superdex 75 HR column chromatography was further purified by reversephase HPLC using a Cosmosil 5C18 AR-II (Nacalai Tesque) column (2ϫ150 mm). The N-terminal amino acid sequence was determined using the Protein Sequencing System (Model HP G1005A, Hewlett-Packard, Palo Alto, CA, U.S.A.).
Measurement of Protease Inhibitory Activity
Inhibitory activities toward trypsin (TPCK-treated, Sigma), subtilisin (Sigma), and a-chymotrypsin (Sigma) were measured as described by Kojima et al., 7) except that 100 mM Tris-HCl buffer (pH 7.5) was used for subtilisin.
Measurement of ALP Activity in the Presense of Proteases
The proteases used were trypsin, subtilisin, and achymotrypsin. A mixture of S-ALP (0.1 mU) and protease (from 15 mg to 1.5 mg) in 75 ml of 1 mM Tris-HCl buffer (pH 8.0) was incubated at 37°C for 10 min. Twenty-five microliters of substrate solution (20 mM NPPC or 20 mM pNPP) was added to the preincubation mixtures and incubated at 37°C for 60 min. The reaction was stopped by adding 0.1 M NaOH 100 ml and the absorbance was measured at 405 nm.
RESULTS AND DISCUSSION
Purification of ALP As mentioned in MATERIALS AND METHODS the freeze-dried culture supernatant of S. hiroshimensis was initially fractionated on Sephadex G-75 Superfine column chromatography, and the ALP fractions were obtained. With Pal-G column chromatography (Fig. 1a) , most of the enzyme activity was eluted from the column with the buffer containing 0.5% (w/v) Triton X-100. The enzyme was purified approximately 10 times in this step. Figure 1b shows the elution profile on the FPLC system using Superdex 75 HR column chromatography. The enzyme activity was separated into two distinct peaks, fraction I and fraction II. Fraction II was designated as S-ALP. A summary of the purification of the ALPs from the culture supernatant of S. hiroshimensis is shown in Table 1 . S-ALP was purified 6.7-fold to a final specific activity of 10 mU/mg of protein with 3.4% recovery.
The purity and homogeneity of fraction I and S-ALP were determined by SDS-PAGE. The peak I preparation gave a broad band on SDS-PAGE under reducing conditions (Fig.  2a, lane 2) . S-ALP gave only a single band on the same SDS-PAGE (Fig. 2a, lane 3) . All subsequent experiments for the biochemical and biological characterizations were performed using only S-ALP.
Purification of ALP using the Pal-G column (Fig. 1a) was sufficient to recover the homogeneous enzyme protein. This result seems to show that Pal-G is useful tool for the purification of phosphatase in addition to lipase and phospholipase. 16, 18) Enzymatic Properties of S-ALP The relative molecular mass of S-ALP was estimated to be 14500 by FPLC gel fil- tration. SDS-PAGE under both reducing (Fig. 2a) and nonreducing (data not shown) conditions gave a molecular mass of 14200. The SSI-like proteins were composed about 110 amino acids that existed as stable dimer proteins, 8, 10) but S-ALP could be regarded as a monomer protein and a subtilisin inhibitor as reported by Kourteva and Boteva.
11) The isoelectric point was determined to be 9.2 (Fig. 2b) .
The optimum pH for S-ALP was 9.5 under with both substrates NPPC and pNPP (Fig. 3) . S-ALP had the optimum temperature of 50-60°C, and was stable in the temperature range from 40 to 50°C. At a concentration of 1 mM, ZnCl 2 and EDTA for the enzyme on pNPP caused 55% and 40% inhibition, respectively. SDS (1%) exerted a 65% inhibition. S-ALP exhibited simple Michaelis-Menten kinetics. The biochemical constants K m and V max were caluculated using NPPC as the substrate, resulting in a K m value of 9.7ϫ10 Ϫ5 M and a V max value of 9.9 nmol/min/mg. The K m and V max values for pNPP as the substrate were found to be 3.8ϫ10 Ϫ6 M and 4.8 nmol/min/mg, respectively. S-ALP was distinctly different from the other Streptomyces ALPs in its molecular mass, isoelectric point, and Ca ϩϩ requirement. 5, 19) N-Terminal Sequence of S-ALP Automated Edman degradation determined the partial N-terminal amino acid sequence (25 residues) of S-ALP to be S-
We did not completely detect other N-terminal sequences different from this sequence in S-ALP. This result also shows that S-ALP is a purified protein. From the DNASIS analysis, the N-terminal sequence of S-ALP showed a low homology (only 24, 4 and 28%) to the N-terminal sequences of each phospholipase C from Streptomyces albus and Streptomyces exfoliatus, and of the alkaline phosphatase from Streptomyces griseus. On the other hand, the N-terminal sequence of S-ALP showed a high identity (60-72%) with various protease inhibitors produced by Streptomyces species through similarity searches using BLAST algorithms (Table 2) .
Protease Inhibition Activity of S-ALP Figure 4 shows the inhibitory effect of S-ALP on the activity of three proteases. S-ALP showed dose-dependent specific inhibitory activity against trypsin and strong inhibition against subtilisin, (a) (b) ᭺, acetate-NaOH; ᭝, phosphate-NaOH; ᮀ, Tris-HCl; ᭛, glycine-NaOH. and had no effect on a-chymotrypsin. The inhibitory specificity is similar to that of the SSI-like proteins because of the strong inhibition against subtilisin compared with trypsin. 8, 10) On the basis of the N-terminal amino acid sequence, the structural characteristics, and the inhibitory properties, S-ALP could be defined as a novel extracellular protease inhibitor from Streptomycetes. Thus S-ALP is a novel protein with ALP and protease inhibitor activities. It appears that S-ALP acts as a multifunctional protein both for dephosphorylation of biologically active intermediates by ALP activity, [1] [2] [3] [4] [5] and for the inhibitory regulation of proteases by protease inhibitory activity, similar to the SSI-like proteins. [6] [7] [8] [9] [10] [11] 
ALP Activity of S-ALP in the Presence of Proteases
The ALP activity of S-ALP in the presence of various concentrations of proteases was not inactivated (data not shown). This shows that the ALP activity of S-ALP is not influenced by the proteases. This may demonstrate that the ALP part of S-ALP is different from the protease inhibitor part. A detailed characterization of the structure and functions of S-ALP is now in progress.
